Keratin 1 expression in endothelia and mesenchymal tumors: An immunohistochemical analysis of normal and neoplastic tissues

Human Pathology

Volumn 32, Issue 8, 2001, Pages 873-879

  Remotti, Fabrizio ^a   Fetsch, John F ^a   Miettinen, Markku ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Carcinoma; Epithelioid sarcoma; Immunohistochemistry; Keratin 1; Kininogen receptor; Synovial sarcoma; Vascular tumors

Indexed keywords

KERATIN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYMOMA; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; TISSUE PREPARATION; VASCULAR ENDOTHELIUM; VASCULAR TUMOR;

EID: 0034876577     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.26466     Document Type: Article

References (26)

1. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
2. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns
3. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
4. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression
5. Keratin immunohistochemistry: Update of applications and pitfalls
6. Biology of disease. Classification of human epithelia and their neoplasm using monoclonal antibodies to keratins: Strategies, applications, and limitations
7. Chromosomal assignments of human type I and type II cytokeratin genes to different chromosomes
8. A group of type I keratin genes on human chromosome 17: Characterization and expression
9. Three epidermal and one simple epithelial type II keratin genes map to chromosome 12
10. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression
11. Smooth muscle cells can express cytokeratins of "simple" epithelium
12. Transient co-expression of desmin and cytokeratins 8 and 18 in developing myocardial cells of some vertebrate species
13. Reactive and neoplastic serosal tissue. A light microscopic, ultrastructural, and immunocytochemical study
14. Anomalous cytokeratin expression in malignant melanoma: One- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas
15. Cytokeratins in certain endothelial and smooth muscle cells of two taxonomically distant vertebrate species, Xenopus laevis and man
16. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors - Implications in tumor diagnosis
17. Cytokeratin expression in epithelioid vascular neoplasms
18. Epithelioid angiosarcoma of the adrenal glands. A clinicopathologic study of nine cases with a discusson of the implications of finding "epithelial-specific" markers
19. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells
20. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gClqR of vascular endothelial cells and with aggregated Aβ protein of Alzheimer's disease
21. Cytokeratin 1 and gClqR mediate high molecular weight kininogen binding to endothelial cells
22. Mapping binding domains of kininogens on endothelial cell cytokeratin 1
23. Plasma contact activation: A revised hypothesis
24. Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occuring at different levels of regulation
25. Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes
26. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator